3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
32
Metastatic Castration-resistant Prostate Cancer
3
Prostatic Diseases
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Urogenital Neoplasms
1
Thrombocytopenia
1
Prostatic Neoplasms, Castration-Resistant
1
Prostate Cancer Metastatic
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Hormone Naive Prostate Cancer
1
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
1
Liver Neoplasms
1
High-Risk Localized Prostate Cancer
1
Glioma
1
Glioblastoma
1
Genital Neoplasms, Male
1
Genital Diseases, Male
1
Disease
1
Cytopenia
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Astrocytoma
1
Anemia
1
Interventions
enzalutamide
6
Abiraterone Acetate
5
abiraterone
2
Prednisone
2
pembrolizumab
1
darolutamide
1
cabazitaxel
1
apalutamide
1
TVB-2640
1
Standard of Care
1
Radiosurgery
1
Pluvicto
1
Photons
1
Omeprazole
1
Nivolumab
1
Ipilimumab
1
Gonadotropin-Releasing Hormone
1
Exome Sequencing
1
Drug Therapy
1
CTLA-4 Antigen
1
Artificial Intelligence
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostatic Neoplasms, Castration-Resistant
×
Pluvicto
×
Clear all
NCT07587814
2026-05-14
COCORIVO
Centre Henri Becquerel
Phase NA
Not yet recruiting
100 enrolled